-

$undefined

N/A

(N/A)

Vigil Neuroscience NASDAQ:VIGL

Location: | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-1.308M

Cash

97.8M

Avg Qtr Burn

-12.81M

Short % of Float

1.51%

Insider Ownership

18.13%

Institutional Own.

68.32%

Qtr Updated

12/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Iluzanebart (VGL101) Details Adult onset leukoencephalopathy w/ axonal spheroids & pigmented glia	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VG-3927 Details Alzheimer's disease	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.